Glasshouse Advisory’s R&D Tax and EMDG practices have transferred to leading independent assurance, tax and advisory firm, Grant Thornton.
Raising equity is a common dilemma for early stage and high-growth companies with few tangible assets. Losses caused by investment in R&D and marketing together with a weak balance sheet can result in awkward conversations with potential investors. During the last year, we have helped half a dozen companies communicate the value of their IP and early stage business to investors.
An interesting case involves a small mining equipment company with a patent portfolio protecting technology that enables the exploitation of shale gas and geothermal reserves that had previously been uneconomic. Although the technology was only at the prototype stage, its benefits had been sufficiently well proven to attract the attention of an investment bank and international oil developer.
Our IP valuation report provided the potential investors with confidence in the economic strength and value of the company’s core asset: its patent portfolio. Our client believes that the valuation report was instrumental in securing a minority investment for $40 million.
The contents of the valuation report improved the line of sight between the vendor’s IP and future earnings by: